|
|
||||||||
1 Department of Medicine and Therapeutics, Mater Misericordiae Hospital, and 2 Department of Human Anatomy and Physiology, University College Dublin, Dublin 2, Ireland
Chronic hypercapnia is commonly found in patients with
severe hypoxic lung disease and is associated with a greater elevation of pulmonary arterial pressure than that due to hypoxia alone. We
hypothesized that hypercapnia worsens hypoxic pulmonary hypertension by
augmenting pulmonary vascular remodeling and hypoxic pulmonary vasoconstriction (HPV). Rats were exposed to chronic hypoxia
[inspiratory O2 fraction
(FIO2) = 0.10],
chronic hypercapnia (inspiratory CO2 fraction = 0.10),
hypoxia-hypercapnia (FIO2 = 0.10, inspiratory CO2 fraction = 0.10), or room air. After 1 and 3 wk of exposure, muscularization of
resistance blood vessels and hypoxia-induced hematocrit elevation were
significantly inhibited in hypoxia-hypercapnia compared with hypoxia
alone (P < 0.001, ANOVA). Right
ventricular hypertrophy was reduced in hypoxia-hypercapnia compared
with hypoxia at 3 wk (P < 0.001, ANOVA). In isolated, ventilated, blood-perfused lungs, basal pulmonary
arterial pressure after 1 wk of exposure to hypoxia (20.1 ± 1.8 mmHg) was significantly (P < 0.01, ANOVA) elevated compared with control conditions (12.1 ± 0.1 mmHg)
but was not altered in hypoxia-hypercapnia (13.5 ± 0.9 mmHg) or
hypercapnia (11.8 ± 1.3 mmHg). HPV
(FIO2 = 0.03) was attenuated
in hypoxia, hypoxia-hypercapnia, and hypercapnia compared with control (P < 0.05, ANOVA). Addition of
N
-nitro-L-arginine
methyl ester (10
4 M), which
augmented HPV in control, hypoxia, and hypercapnia, significantly
reduced HPV in hypoxia-hypercapnia. Chronic hypoxia caused impaired
endothelium-dependent relaxation in isolated pulmonary arteries, but
coexistent hypercapnia partially protected against this effect. These
findings suggest that coexistent hypercapnia inhibits hypoxia-induced
pulmonary vascular remodeling and right ventricular hypertrophy,
reduces HPV, and protects against hypoxia-induced impairment of
endothelial function.
pulmonary hypertension; nitric oxide; endothelium; vascular resistance
This article has been cited by other articles:
![]() |
M.-C. Cathcart, R. Tamosiuniene, G. Chen, T. G. Neilan, A. Bradford, K. J. O'Byrne, D. J. Fitzgerald, and G. P. Pidgeon Cyclooxygenase-2-Linked Attenuation of Hypoxia-Induced Pulmonary Hypertension and Intravascular Thrombosis J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 51 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, F. Su, A. Bruhn, X. Yang, and J.-L. Vincent Acute Hypercapnia Improves Indices of Tissue Oxygenation More than Dobutamine in Septic Shock Am. J. Respir. Crit. Care Med., January 15, 2008; 177(2): 178 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Snow, V. Kitzis, C. E. Norton, S. N. Torres, K. D. Johnson, N. L. Kanagy, B. R. Walker, and T. C. Resta Differential effects of chronic hypoxia and intermittent hypocapnic and eucapnic hypoxia on pulmonary vasoreactivity J Appl Physiol, January 1, 2008; 104(1): 110 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kolar, J. Jezkova, P. Balkova, J. Breh, J. Neckar, F. Novak, O. Novakova, H. Tomasova, M. Srbova, B. Ost'adal, et al. Role of oxidative stress in PKC-{delta} upregulation and cardioprotection induced by chronic intermittent hypoxia Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H224 - H230. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Kantores, P. J. McNamara, L. Teixeira, D. Engelberts, P. Murthy, B. P. Kavanagh, and R. P. Jankov Therapeutic hypercapnia prevents chronic hypoxia-induced pulmonary hypertension in the newborn rat Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L912 - L922. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Ghofrani, R. Voswinckel, F. Reichenberger, N. Weissmann, R. T. Schermuly, W. Seeger, and F. Grimminger Hypoxia- and non-hypoxia-related pulmonary hypertension - Established and new therapies Cardiovasc Res, October 1, 2006; 72(1): 30 - 40. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Hyvelin, K. Howell, A. Nichol, C. M. Costello, R. J. Preston, and P. McLoughlin Inhibition of Rho-Kinase Attenuates Hypoxia-Induced Angiogenesis in the Pulmonary Circulation Circ. Res., July 22, 2005; 97(2): 185 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bradford Festschrift for R. G. O'Regan - Sensing and adaptation to alterations in respiratory gases: oxygen and carbon dioxide: Effects of chronic intermittent asphyxia on haematocrit, pulmonary arterial pressure and skeletal muscle structure in rats Exp Physiol, January 1, 2004; 89(1): 44 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Howell, H. Ooi, R. Preston, and P. McLoughlin Festschrift for R. G. O'Regan - Sensing and adaptation to alterations in respiratory gases: oxygen and carbon dioxide: Structural basis of hypoxic pulmonary hypertension: the modifying effect of chronic hypercapnia Exp Physiol, January 1, 2004; 89(1): 66 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. McGuire, M. MacDermott, and A. Bradford The Effects of Chronic Episodic Hypercapnic Hypoxia on Rat Upper Airway Muscle Contractile Properties and Fiber-Type Distribution Chest, October 1, 2002; 122(4): 1400 - 1406. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. McGuire and A. Bradford Chronic intermittent hypercapnic hypoxia increases pulmonary arterial pressure and haematocrit in rats Eur. Respir. J., August 1, 2001; 18(2): 279 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Fagan Physiological and Genomic Consequences of Intermittent Hypoxia: Selected Contribution: Pulmonary hypertension in mice following intermittent hypoxia J Appl Physiol, June 1, 2001; 90(6): 2502 - 2507. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |